Cerebral hypoperfusion in post-COVID-19 cognitively impaired subjects revealed by arterial spin labeling MRI.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
10 04 2023
Historique:
received: 23 12 2022
accepted: 24 03 2023
medline: 12 4 2023
entrez: 10 4 2023
pubmed: 11 4 2023
Statut: epublish

Résumé

Cognitive impairment is one of the most prevalent symptoms of post Severe Acute Respiratory Syndrome COronaVirus 2 (SARS-CoV-2) state, which is known as Long COVID. Advanced neuroimaging techniques may contribute to a better understanding of the pathophysiological brain changes and the underlying mechanisms in post-COVID-19 subjects. We aimed at investigating regional cerebral perfusion alterations in post-COVID-19 subjects who reported a subjective cognitive impairment after a mild SARS-CoV-2 infection, using a non-invasive Arterial Spin Labeling (ASL) MRI technique and analysis. Using MRI-ASL image processing, we investigated the brain perfusion alterations in 24 patients (53.0 ± 14.5 years, 15F/9M) with persistent cognitive complaints in the post COVID-19 period. Voxelwise and region-of-interest analyses were performed to identify statistically significant differences in cerebral blood flow (CBF) maps between post-COVID-19 patients, and age and sex matched healthy controls (54.8 ± 9.1 years, 13F/9M). The results showed a significant hypoperfusion in a widespread cerebral network in the post-COVID-19 group, predominantly affecting the frontal cortex, as well as the parietal and temporal cortex, as identified by a non-parametric permutation testing (p < 0.05, FWE-corrected with TFCE). The hypoperfusion areas identified in the right hemisphere regions were more extensive. These findings support the hypothesis of a large network dysfunction in post-COVID subjects with cognitive complaints. The non-invasive nature of the ASL-MRI method may play an important role in the monitoring and prognosis of post-COVID-19 subjects.

Identifiants

pubmed: 37037833
doi: 10.1038/s41598-023-32275-3
pii: 10.1038/s41598-023-32275-3
pmc: PMC10086005
doi:

Substances chimiques

Spin Labels 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5808

Informations de copyright

© 2023. The Author(s).

Références

Neuroimage. 2009 Jan 1;44(1):83-98
pubmed: 18501637
Tomography. 2022 Jan 17;8(1):229-244
pubmed: 35076603
Magn Reson Med. 2011 Apr;65(4):1173-83
pubmed: 21337417
Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2543-2557
pubmed: 33452633
Hum Brain Mapp. 2002 Jan;15(1):1-25
pubmed: 11747097
J Neurol. 2022 Jul;269(7):3400-3412
pubmed: 35249144
Nat Med. 2021 Apr;27(4):601-615
pubmed: 33753937
Neuroimage. 2014 Nov 15;102 Pt 1:49-59
pubmed: 23792219
Brain Commun. 2022 Jan 19;4(1):fcab295
pubmed: 35128398
Lancet Psychiatry. 2021 May;8(5):416-427
pubmed: 33836148
Neuroimage. 2004;23 Suppl 1:S220-33
pubmed: 15501093
Brain. 2020 Oct 1;143(10):3104-3120
pubmed: 32637987
Eur J Neurol. 2020 Dec;27(12):2651-2657
pubmed: 32881133
Brain Behav Immun. 2021 May;94:138-147
pubmed: 33639239
Continuum (Minneap Minn). 2021 Dec 1;27(6):1586-1601
pubmed: 34881727
Aging Clin Exp Res. 2022 Feb;34(2):375-382
pubmed: 34313961
J Nucl Med. 2021 Jul 1;62(7):910-915
pubmed: 33789937
J Magn Reson Imaging. 2022 Dec 6;:
pubmed: 36472248
Parkinsonism Relat Disord. 2019 Aug;65:105-110
pubmed: 31147224
Eur J Neurol. 2021 Oct;28(10):3245-3253
pubmed: 33576150
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
PLoS One. 2015 May 06;10(5):e0123975
pubmed: 25946055
Magn Reson Med. 2019 Jun;81(6):3734-3744
pubmed: 30828873
Nature. 2022 Apr;604(7907):697-707
pubmed: 35255491
J Neurol. 2022 Feb;269(2):587-596
pubmed: 34386903
Brain Behav. 2022 Apr;12(4):e2513
pubmed: 35290729
Viruses. 2021 Nov 15;13(11):
pubmed: 34835088
J Neurol Sci. 2022 Oct 15;441:120355
pubmed: 35994869
Brain. 2021 May 7;144(4):1263-1276
pubmed: 33822001
Brain Behav Immun. 2022 Mar;101:93-135
pubmed: 34973396
J Neurol. 2021 Oct;268(10):3569-3573
pubmed: 33709220
Brain. 2011 Mar;134(Pt 3):845-55
pubmed: 21310726
Clin Infect Dis. 2021 Sep 7;73(5):e1089-e1098
pubmed: 33220049
JAMA Netw Open. 2021 Oct 1;4(10):e2128568
pubmed: 34643720
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
JAMA Netw Open. 2021 Oct 1;4(10):e2130645
pubmed: 34677597
Magn Reson Med. 2015 Jan;73(1):102-16
pubmed: 24715426
J Alzheimers Dis. 2021;82(3):883-898
pubmed: 34092646
Neuroimage. 2009 Apr 15;45(3):795-809
pubmed: 19162204
Continuum (Minneap Minn). 2018 Jun;24(3, BEHAVIORAL NEUROLOGY AND PSYCHIATRY):704-726
pubmed: 29851874
Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2823-2833
pubmed: 33501506
Neurol Sci. 2021 Aug;42(8):3423-3425
pubmed: 33763811
Eur Arch Psychiatry Clin Neurosci. 2012 Feb;262(1):69-77
pubmed: 21786091
Magn Reson Med. 1998 Sep;40(3):383-96
pubmed: 9727941
MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998
pubmed: 32730238

Auteurs

Miloš Ajčević (M)

Department of Engineering and Architecture, University of Trieste, Trieste, Italy.

Katerina Iscra (K)

Department of Engineering and Architecture, University of Trieste, Trieste, Italy.

Giovanni Furlanis (G)

Clinical Unit of Neurology, Department of Medicine, Surgery and Health Sciences, Trieste University Hospital-ASUGI, University of Trieste, Trieste, Italy.

Marco Michelutti (M)

Clinical Unit of Neurology, Department of Medicine, Surgery and Health Sciences, Trieste University Hospital-ASUGI, University of Trieste, Trieste, Italy.

Aleksandar Miladinović (A)

Department of Engineering and Architecture, University of Trieste, Trieste, Italy.

Alex Buoite Stella (A)

Clinical Unit of Neurology, Department of Medicine, Surgery and Health Sciences, Trieste University Hospital-ASUGI, University of Trieste, Trieste, Italy.

Maja Ukmar (M)

Radiology Unit, Department of Medicine, Surgery and Health Sciences, Trieste University Hospital-ASUGI, University of Trieste, Trieste, Italy.

Maria Assunta Cova (MA)

Radiology Unit, Department of Medicine, Surgery and Health Sciences, Trieste University Hospital-ASUGI, University of Trieste, Trieste, Italy.

Agostino Accardo (A)

Department of Engineering and Architecture, University of Trieste, Trieste, Italy.

Paolo Manganotti (P)

Clinical Unit of Neurology, Department of Medicine, Surgery and Health Sciences, Trieste University Hospital-ASUGI, University of Trieste, Trieste, Italy. pmanganotti@units.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH